These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 157787)

  • 21. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
    Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE
    Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proliferation of purified murine hemopoietic stem cells in serum-free cultures stimulated with purified stem-cell-activating factor.
    Migliaccio AR; Visser JW
    Exp Hematol; 1986 Dec; 14(11):1043-8. PubMed ID: 3536544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth and differentiation of rat bone marrow stem cells in diffusion chamber culture.
    Kurrle E; Hoelzer D; Harriss EB
    Exp Hematol; 1977; 5(4):241-9. PubMed ID: 891663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Granulocyte chalone: tissue specificity of action in short-term cultures].
    Schunck H; Schütt M; Langen P
    Acta Biol Med Ger; 1978; 37(4):593-600. PubMed ID: 153696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells.
    Ottmann OG; Pelus LM
    J Immunol; 1988 Apr; 140(8):2661-5. PubMed ID: 3258618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of humoral factors on amplification of nonrecognizable erythrocytic and granulocytic precursors.
    Cronkite EP; Carsten AL; Cohen R; Miller ME; Moccia G
    Blood Cells; 1979 Aug; 5(3):331-50. PubMed ID: 555692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effect of L3T4+ cells on recovery from total-body irradiation.
    Pantel K; Nakeff A
    Exp Hematol; 1990 Sep; 18(8):863-7. PubMed ID: 1974863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of methotrexate on murine bone marrow cells in vitro: evidence of a reversible antiproliferative action.
    Strømhaug A; Warren DJ; Slørdal L
    Exp Hematol; 1995 May; 23(5):439-43. PubMed ID: 7720815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of natural killer cells on the development of syngeneic hematopoietic progenitors.
    Holmberg LA; Miller BA; Ault KA
    J Immunol; 1984 Dec; 133(6):2933-9. PubMed ID: 6436368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-CFU-f: young-type stromal stem cells in murine bone marrow following administration of DNA inhibitors.
    Ben-Ishay Z; Prindull G; Sharon S; Borenstein A
    Int J Cell Cloning; 1986 Mar; 4(2):126-34. PubMed ID: 3958511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic effect of stem cell factor with interleukin-3 or granulocyte-macrophage colony-stimulating factor on the proliferation of murine primitive hematopoietic progenitors.
    Wu DD; Nayar R; Keating A
    Exp Hematol; 1994 Jun; 22(6):495-500. PubMed ID: 7514543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal G1-chalone and transforming growth factor-beta are two different endogenous inhibitors of epidermal cell proliferation.
    Richter KH; Schnapke R; Clauss M; Fürstenberger G; Hinz D; Marks F
    J Cell Physiol; 1990 Mar; 142(3):496-504. PubMed ID: 1968903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of myleran on murine hemopoiesis. I. Granulocytic cell line specificity of action on progenitor cells.
    Delmonte L
    Cell Tissue Kinet; 1978 Jul; 11(4):347-58. PubMed ID: 308393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effects of tumor necrosis factor on hematopoiesis seen in vitro are translated to increased numbers of both committed and multipotent progenitors in TNF-deficient mice.
    Drutskaya MS; Ortiz M; Liepinsh DJ; Kuprash DV; Nedospasov SA; Keller JR
    Exp Hematol; 2005 Nov; 33(11):1348-56. PubMed ID: 16263419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycythemia vera. Increased expression of normal committed granulocytic stem cells in vitro after exposure of marrow to tritiated thymidine.
    Singer JW; Fialkow PJ; Adamson JW; Steinmann L; Ernst C; Murphy S; Kopecky KJ
    J Clin Invest; 1979 Nov; 64(5):1320-4. PubMed ID: 500813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of a synthetic pentapeptide on hemopoietic stem cells in vitro and in vivo.
    Laerum OD; Paukovits WR
    Exp Hematol; 1984 Jan; 12(1):7-17. PubMed ID: 6230248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of stem cell proliferation stimulators and inhibitors by haemopoietic cell suspensions.
    Wright EG; Lord BI
    Biomedicine; 1978; 28(3):156-60. PubMed ID: 308819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition by cholera toxin of clonal growth of murine granulocyte/macrophage progenitor cells in soft agar cultures.
    Lenz R; Pluznik DH
    Exp Hematol; 1982 Aug; 10(7):620-7. PubMed ID: 6290248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pluripotent (CFU-S) and granulocyte-committed (CFU-C) stem cells in intact and 89Sr marrow-ablated S1/S1d mice.
    Adler SS; Trobaugh FE
    Cell Tissue Kinet; 1978 Sep; 11(5):555-66. PubMed ID: 719697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell cycle-dependent heat sensitization of murine granulocyte-macrophage progenitor cells in regenerating marrow.
    Kobayashi E; Yamagishi M; Kamamoto T; Yoshida Y; Uchino H
    Cancer Res; 1985 Apr; 45(4):1459-63. PubMed ID: 3978612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.